- Home
- RMBL vs MGNX Comparison
RMBL vs MGNX Comparison
Compare RMBL & MGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RMBL
- MGNX
- Stock Information
- Founded
- RMBL 2013
- MGNX 2000
- Country
- RMBL United States
- MGNX United States
- Employees
- RMBL N/A
- MGNX N/A
- Industry
- RMBL EDP Services
- MGNX Biotechnology: Pharmaceutical Preparations
- Sector
- RMBL Technology
- MGNX Health Care
- Exchange
- RMBL Nasdaq
- MGNX Nasdaq
- Market Cap
- RMBL 205.0M
- MGNX 202.7M
- IPO Year
- RMBL N/A
- MGNX 2013
- Fundamental
- Price
- RMBL $4.00
- MGNX $2.76
- Analyst Decision
- RMBL Hold
- MGNX Hold
- Analyst Count
- RMBL 3
- MGNX 10
- Target Price
- RMBL $5.67
- MGNX $7.17
- AVG Volume (30 Days)
- RMBL 65.7K
- MGNX 768.5K
- Earning Date
- RMBL 03-13-2025
- MGNX 03-06-2025
- Dividend Yield
- RMBL N/A
- MGNX N/A
- EPS Growth
- RMBL N/A
- MGNX N/A
- EPS
- RMBL N/A
- MGNX N/A
- Revenue
- RMBL $1,250,800,000.00
- MGNX $141,329,000.00
- Revenue This Year
- RMBL N/A
- MGNX $174.73
- Revenue Next Year
- RMBL $5.64
- MGNX N/A
- P/E Ratio
- RMBL N/A
- MGNX N/A
- Revenue Growth
- RMBL N/A
- MGNX 16.68
- 52 Week Low
- RMBL $3.13
- MGNX $2.34
- 52 Week High
- RMBL $8.17
- MGNX $21.88
- Technical
- Relative Strength Index (RSI)
- RMBL 36.07
- MGNX 45.32
- Support Level
- RMBL $4.07
- MGNX $2.34
- Resistance Level
- RMBL $4.35
- MGNX $2.95
- Average True Range (ATR)
- RMBL 0.24
- MGNX 0.17
- MACD
- RMBL 0.01
- MGNX 0.03
- Stochastic Oscillator
- RMBL 0.00
- MGNX 61.76
About RMBL RumbleOn Inc. Class B
RumbleON Inc is a USA-based online retailer that allows both consumers and dealers to Buy-Sell-Trade-Finance pre-owned motorcycles in an efficient, fast, transparent, and engaging experience. Its segments include power sports, automotive, and vehicle logistics. Powersports and automotive segments consist of the distribution of pre-owned vehicles. The Powersports segment that derives the majority of revenue consists of the distribution principally of motorcycles and other powersports vehicles, while the automotive segment distributes cars and trucks. The vehicle Logistics and transportation service segment offers nationwide automotive transportation services between dealerships and auctions.
About MGNX MacroGenics Inc.
Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. It's a pipeline of product candidates designed to target either various tumor-associated antigens or immune checkpoint molecules. Its pipeline MGC018 (B7-H3), Lorigerlimab (PD-1 x CTLA-4), Tebotelimab (PD-1 x LAG-3), MGD024 (CD123 x CD3), IMGC936 (ADAM9), Enoblituzumab (anti-B7-H3), Retifanlimab (PD-1), and MGD014 (HIV x CD3).